- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Yousif Capital Management Trims Stake in Eli Lilly
Investment firm reduces position in pharmaceutical giant by 4.5% in Q4 2025
Apr. 12, 2026 at 11:56am
Got story updates? Submit your updates here. ›
Yousif Capital Management's reduced stake in pharmaceutical giant Eli Lilly reflects broader trends in the healthcare investment landscape.Indianapolis TodayYousif Capital Management LLC reduced its stake in Eli Lilly and Company (NYSE:LLY) by 4.5% in the fourth quarter of 2025, according to a recent SEC filing. The investment firm now owns 76,903 shares of the pharmaceutical company's stock, valued at $80.08 million.
Why it matters
Eli Lilly is one of the world's largest pharmaceutical companies, with a diverse portfolio of blockbuster drugs. Institutional investors closely monitor changes in ownership of the stock, as it can signal broader market sentiment and investment trends in the healthcare sector.
The details
Yousif Capital Management sold 3,601 shares of Eli Lilly stock during the fourth quarter, reducing its total position to 76,903 shares. The firm's holdings in Eli Lilly now make up 0.9% of its overall investment portfolio, making it the 12th largest holding.
- Yousif Capital Management filed its Q4 2025 SEC report in April 2026.
The players
Yousif Capital Management LLC
An investment management firm that owns a $80.08 million position in Eli Lilly and Company.
Eli Lilly and Company
A global pharmaceutical company that researches, develops, manufactures, and commercializes a broad range of medicines and therapies.
The takeaway
Yousif Capital Management's reduced stake in Eli Lilly reflects broader market trends, as investors closely monitor the pharmaceutical industry's performance and outlook. The firm's holdings in the stock remain substantial, indicating its continued confidence in Eli Lilly's long-term growth potential.
